Annovis BioInc Net Income vs. Total Asset

ANVS
 Stock
  

USD 13.44  0.94  7.52%   

For Annovis BioInc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Annovis BioInc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Annovis BioInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Annovis BioInc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Annovis BioInc over time as well as its relative position and ranking within its peers. Please continue to Trending Equities.
  
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
106.7 M
Return On Assets
(0.44) 
Return On Equity
(0.74) 
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis BioInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Annovis BioInc Total Asset vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Annovis BioInc's current stock value. Our valuation model uses many indicators to compare Annovis BioInc value to that of its competitors to determine the firm's financial worth.
Annovis BioInc is rated fourth in net income category among related companies. It is rated third in total asset category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Annovis BioInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Annovis BioInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Annovis BioInc's earnings, one of the primary drivers of an investment's value.

Annovis Total Asset vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Annovis BioInc 
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
(14.49 B)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Annovis BioInc 
Total Asset 
 = 
Tangible Assets 
Intangible Assets 
46 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Annovis Total Asset Comparison

Annovis BioInc is currently under evaluation in total asset category among related companies.

Annovis BioInc Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Annovis BioInc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Annovis BioInc will eventually generate negative long term returns. The profitability progress is the general direction of Annovis BioInc's change in net profit over the period of time. It can combine multiple indicators of Annovis BioInc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Annovis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Annovis BioInc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Annovis BioInc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Annovis BioInc's important profitability drivers and their relationship over time.

Use Annovis BioInc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.

Annovis BioInc Pair Trading

Annovis BioInc Pair Trading Analysis

The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.
The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Annovis BioInc position

In addition to having Annovis BioInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corporate Bonds Thematic Idea Now

Corporate Bonds
Corporate Bonds Theme
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Trending Equities. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Annovis BioInc price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
To fully project Annovis BioInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Annovis BioInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Annovis BioInc's income statement, its balance sheet, and the statement of cash flows.
Potential Annovis BioInc investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Annovis BioInc investors may work on each financial statement separately, they are all related. The changes in Annovis BioInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis BioInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.